Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Zura Bio Q1 2024 GAAP EPS $(0.02) Beats $(0.23) Estimate

Author: Benzinga Newsdesk | May 09, 2024 06:16am
Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.23) by 91.3 percent.

Posted In: ZURA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist